For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
Blog
This week in health care policy: September 21–25, 2026
Innovation watch FDA approves the first treatment for Sanfilippo syndrome. On September 17, the FDA approved Ultragenyx’s Fayuvi, a one-time…
Blog
How The No Surprises Act worsened the problem of surprise bills
Next week, Sen. Bill Cassidy (R-LA) will convene a roundtable to discuss adjustments to the 2020 No Surprises Act, which has come under…
Search Posts
Blog
Registering Some Problems With REACH
The Wall Street Journal reports today that U.S. and European firms were unsuccessful in an attempt to make the proposed chemicals policy in…
Op-Eds
Big business loses a buddy with Mark Foley resignation
WASHINGTON – We’re still figuring out who knew what and when about former Florida Rep. Mark Foley’s behavior toward pages, but the disgraced…
Op-Eds
A Nobel Prize For Pinpointing U.S. Greatness
America is now five for five in the Nobel Prizes this year. And the announcement of Edmund Phelps as the economics recipient is…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. TECHNOLOGY Google buys Internet video pioneer YouTube for $1.65 billion.
Newsletter
The Competitive Enterprise Institute Daily Update
<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Issues in the News 1. ENERGY…
Blog
Pesticide Bans No Minor Mistake
Tina’s Rosenberg’s article in today’s New York Times addresses the devastating impact that misguided bans of the pesticide DDT have had on…